Service

CAP Reproductive Laboratory Accreditation Consulting

CAP reproductive laboratory accreditation is the College of American Pathologists' Reproductive Accreditation Program for laboratories that perform embryology, andrology and related testing, designed with the American Society for Reproductive Medicine and inspected on site every two years. This page is for fertility program laboratories and quality managers preparing for CAP reproductive accreditation or building the laboratory's operating procedures. Integral Healthcare Solutions (IHS) drafts the traceability and quality procedures for reproductive laboratory accreditation; your embryologists and physicians own methods and treatment.

Last reviewed: October 2026.

What is CAP reproductive laboratory accreditation?

CAP's Reproductive Accreditation Program page, as read October 2, 2026, says the program was built for reproductive laboratories together with the American Society for Reproductive Medicine, and says the Society for Assisted Reproductive Technologies (SART) recognizes it as meeting SART's membership requirements for in vitro fertilization facilities (CAP Reproductive Accreditation Program). We have not read SART's own requirements page.

CAP lists the services in scope as embryology, andrology, endocrinology, cryopreservation, reproductive cell and tissue storage, and preimplantation genetic screening or diagnosis (same page, as read October 2, 2026). The governing text is the CAP Reproductive Laboratory Medicine checklist (same page). CAP sells its master checklists as part of its accreditation process (CAP accreditation process, page opened October 3, 2026), and the edition you purchase is the version of record, so IHS works from your copy.

Inspections come every two years, and CAP staffs the inspection team with practicing professionals who have completed CAP's inspector training (CAP, as read October 2, 2026).

Two federal texts may sit alongside the checklist. CLIA, at 42 CFR Part 493, "sets forth the conditions that all laboratories must meet to be certified to perform testing on human specimens" (42 CFR 493.1). FDA's 21 CFR Part 1271 covers human cells, tissues, and cellular and tissue-based products (HCT/Ps), whose definition includes "semen or other reproductive tissue" (21 CFR 1271.3(d)). Part 1271 exists "to create an electronic registration and listing system for establishments that manufacture human cells, tissues, and cellular and tissue-based products (HCT/P's) and to establish donor-eligibility, current good tissue practice, and other procedures to prevent the introduction, transmission, and spread of communicable diseases by HCT/P's" (21 CFR 1271.1(a)).

Who needs it and what triggers it

CAP's page sets eligibility at laboratories that perform any embryology-related procedure, or that perform semen analysis along with at least one other high-complexity test (CAP, as read October 2, 2026). Typical triggers:

How IHS helps

IHS markets a process, applied to the Reproductive Laboratory Medicine checklist your laboratory holds:

  1. Gap assessment against the checklist.
  2. Questionnaires on consent interfaces, specimen identity and traceability, personnel and document control.
  3. Document and evidence mapping: a crosswalk from each checklist requirement to the procedure, log or record that shows it is met.
  4. Drafting traceability, identity-verification, document-control and quality-review procedures for your laboratory director and embryologists to review and approve.
  5. Mock document review against the checklist before the CAP inspection.
  6. Readiness support through inspection and the deficiency response.

What you supply: the checklist, your SOPs, consent forms, and your embryologists, laboratory director and reproductive clinicians.

The limit: laboratory methods and treatment decisions are technical and clinical, and they stay with your team. IHS covers process and records. Your laboratory applies to CAP and hosts the inspection; IHS does not apply on your behalf.

What to have ready

Printable version of this checklist (PDF)

How it compares

The routes below come from the sources' own pages. Which fits depends on your services and your SART plans.

RouteWhat the sources say
CAP Reproductive Accreditation ProgramBuilt with ASRM. CAP reports that SART recognizes it for IVF facility membership, and inspections by a peer team come every two years (CAP, as read October 2, 2026).
CAP Laboratory Accreditation ProgramCAP's general clinical laboratory route, with CMS deeming authority (CAP). The CAP reproductive page is the program CAP names as SART-recognized. See CAP laboratory accreditation.
Other CLIA accreditation organizationsCMS lists ACHC, A2LA, ASHI, AABB, CAP, COLA and The Joint Commission as approved CLIA accreditation organizations (CMS list). We have not reviewed whether SART recognizes them for its membership requirements.
No accreditationIHS's reading (October 2026): the laboratory gives up the SART membership route CAP names, and any FDA Part 1271 obligations that apply to the laboratory are separate (IHS has not reviewed which establishments Part 1271 reaches or its exceptions) (21 CFR 1271.1).

What it costs

The CAP pages we read on October 2, 2026 showed no dollar amounts, and fees depend on scope. CAP's separate application page is not among them. CAP routes cost questions through a fee estimate form, which its accreditation page offers (CAP accreditation, as read October 2, 2026) and its process page repeats (CAP accreditation process, page opened October 3, 2026). The process page also says CAP waives the application fee when a laboratory buys the checklists and applies within six months. Verify current fees with CAP. IHS scopes each engagement after a free introductory call.

What this is not

Frequently asked questions

What is CAP reproductive laboratory accreditation?

It is the College of American Pathologists' Reproductive Accreditation Program, built with the American Society for Reproductive Medicine for reproductive laboratories. As read October 2, 2026, CAP's program page says inspections come every two years, are assessed against its Reproductive Laboratory Medicine checklist, and are carried out by practicing professionals trained as CAP inspectors.

Does an IVF lab need CAP accreditation to be a SART member?

CAP's program page, as read October 2, 2026, says SART recognizes the CAP program as meeting its membership requirements for in vitro fertilization facilities. We have not reviewed SART's own requirements page, so check SART's current terms for what it accepts.

Which fertility labs are eligible for the CAP Reproductive Accreditation Program?

CAP's program page, as read October 2, 2026, sets eligibility at laboratories that perform any embryology-related procedure, or that perform semen analysis along with at least one other high-complexity test.

Does CAP reproductive accreditation cover andrology, embryology and cryostorage together?

Yes. CAP's program page, as read October 2, 2026, lists embryology, andrology, endocrinology, cryopreservation, reproductive cell and tissue storage, and preimplantation genetic screening or diagnosis as in scope.

How often is a CAP-accredited reproductive lab inspected?

Every two years, according to CAP's program page as read October 2, 2026. That page says the inspectors are practicing professionals who have completed CAP's inspector training.

How long does it take to get a fertility lab CAP accredited?

CAP's general process page (opened October 3, 2026) prints week ranges beside its process steps, and the range beside the checklist, scheduling and inspection-day steps is 13 to 24 weeks. That page does not say whether the ranges apply to the reproductive program specifically, so confirm with CAP for your application.

How much does CAP reproductive laboratory accreditation cost?

The CAP pages we read on October 2, 2026 showed no dollar amounts and route cost questions through a fee estimate form. Those pages did not include CAP's application page, which may carry an application fee. Its process page (opened October 3, 2026) says CAP waives the application fee when a laboratory buys the checklists and applies within six months. Verify current fees with CAP. IHS scopes its own work after a free introductory call.

How does FDA's 21 CFR 1271 relate to CAP accreditation?

They are separate. FDA's Part 1271 covers human cells, tissues and cellular and tissue-based products, a definition that includes semen and other reproductive tissue, and sets registration, donor-eligibility and good tissue practice rules. CAP accreditation is a laboratory accreditation against CAP's checklist; holding one does not settle the other.

Should an IVF laboratory choose CAP or The Joint Commission?

CMS lists both as approved CLIA accreditation organizations. CAP's reproductive program page, as read October 2, 2026, says SART recognizes the CAP program for IVF facility membership, and we have not reviewed what SART accepts beyond that. IHS does not make this choice for you.

Does IHS write our embryology methods or apply to CAP for us?

No. IHS drafts traceability, identity-verification, document-control and quality-review procedures for your director and embryologists to approve. Methods and treatment decisions stay with your team, and your laboratory applies to CAP and hosts the inspection.

Recent changes

  • Clinical Laboratory Improvement Amendments: Use Updated Application for Certification

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS updated the Application for Certification (PDF) (form CMS-116) under the Clinical Laboratory Improvement Amendments (CLIA) . The revised form took effect on November 9.”

    Checked

  • Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities

    · Substance Abuse and Mental Health Services Administration

    Full title: Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies (Notice; FR Doc. 2026-22321)

    Substance Abuse and Mental Health Services Administration states: “The Department of Health and Human Services (HHS) provides notice of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.”

    Checked

  • REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment

    · Centers for Medicare & Medicaid Services

    Full title: REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits (QSO-18-14-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-18-14-CLIA, "Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits", on October 16, 2026.

    Checked

  • Clinical Laboratory Improvement Amendments: Provide Input on Proposed Changes by December 7

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS is seeking input on proposed changes to the rules implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Comment period, in the source's words: “Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Checked

  • REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance

    · Centers for Medicare & Medicaid Services

    Full title: REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance (QSO-23-15-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-23-15-CLIA, "REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance", on October 14, 2026.

    Checked

More: Laboratories · all standards changes

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session